Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001140361-17-046253

President & CEO sold 20,000 shares at $45.99 ($919,800)

  • President & CEO acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Abdun-Nabi Daniel President & CEO 2017-12-13 Option exercise +20,000 $14.44 $288,800 224,134 D: show line 1 in the form
Abdun-Nabi Daniel President & CEO 2017-12-13 Sale −20,000 $45.99 $919,800 204,134 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $45.99 · $919,800

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Abdun-Nabi Daniel President & CEO 2017-12-13 Option exercise · Stock Option (Right to Buy) −20,000 21,906 D: show line 3 in the form
Loading xslF345X03/doc1.xml…